Episode: 80 - Vibha Jawa Discusses the Impact of Biologic Molecules and the Future of Immunogenicity
About this episode
Vibha Jawa discusses the future of immunogenicity and the impact of biologic molecules on cancer treatment.
December 13, 2025 | What is next for immunogenicity? In this episode of The Chain, Vibha Jawa, chief scientific officer at EpiVax, provides her thoughts and insights on BiTE molecules, pegylated molecules, and other biologic molecules and their impact on cancer treatment and research with host Rakesh Dixit. Jawa shares the most rewarding project she’s worked on and what therapeutic modality she sees being picked up in the next decade, as well as advice for the next generation of scientists, s...
Topics covered
- immunogenicity
- biologic molecules
- cancer treatment
- BiTE molecules
- pegylated molecules
- scientific insights
More episodes of The Chain: Protein Engineering Podcast
- Episode: 85 - Daniel Chen on Building Multi-Target Drugs with Logic Gating
- Episode: 83 - Patrick Baeuerle and Jeffrey Miller on T Cell and Immune Cell Engagement
- Episode: 82 - PANEL DISCUSSION: Future of Biologic Therapeutics: Will Half-Life Extended Peptides Replace Multispecific Antibodies?
- Episode: 81 - Laszlo Radvanyi on Pushing Boundaries in Cancer Immunotherapy Research
- Episode: 79 - Conversation with Bahija Jallal on the Biggest Anticipated Transformations and Breakthroughs
- Episode: 78 - Shamit Shrivastava on an Interdisciplinary Approach to Antibody Biophysics and Developability
Explore listener stats, chart rankings, contacts and more on the The Chain: Protein Engineering Podcast podcast page.